acluracil: structure
ID Source | ID |
---|---|
PubMed CID | 159901 |
SCHEMBL ID | 9050834 |
MeSH ID | M0059936 |
Synonym |
---|
acluracil |
aclu |
2,4(1h,3h)-pyrimidinedione, 6-chloro-3,5-diethyl-1-(2-propenyl)- |
brn 0748567 |
alcuracil |
uracil, 1-allyl-6-chloro-3,5-diethyl- |
1-allyl-3,5-diethyl-6-chlorouracil |
6-chloro-3,5-diethyl-1-prop-2-enylpyrimidine-2,4-dione |
j9d6da3ii1 , |
unii-j9d6da3ii1 |
20938-38-9 |
5-24-07-00232 (beilstein handbook reference) |
3,5-diethyl-1-allyl-6-chlorouracil |
1-allyl-3,5-diathyl-6-chloruracil |
SCHEMBL9050834 |
DTXSID80175104 |
Q27281372 |
AKOS040750108 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.19) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |